GW572016
Jump to navigation
Jump to search
GW572016 | |
---|---|
Term | GW572016 |
Short definition | GVHD - A condition that occurs when donated stem cells or bone marrow (the transplant) mistake the healthy tissues in the patient's (the host) body and attack it. It can also occur after an organ transplant. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
GW572016 - A drug used with capecitabine or letrozole to treat certain types of HER2-positive breast cancer that have progressed or spread. It is also being studied in the treatment of other types of cancer. GW572016 blocks EGFR and other proteins that may help prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also known as lapatinib ditosylate and Tykerb
External links
- Medical encyclopedia article on GW572016
- Wikipedia's article - GW572016
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski